Top Markets
Coin of the day
Ensysce Biosciences, Inc. Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.

ENSC
Ранг среди акций #19706
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in... Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.
Цена акции
$0.5275
Рыночная капитализация
$1.25M
Изменение (1 день)
-3.56%
Изменение (1 год)
-83.77%
Страна
US
Торговля Ensysce Biosciences, Inc. (ENSC)

Категория

EPS для Ensysce Biosciences, Inc. (ENSC)
EPS по состоянию на September 2025 TTM: $-6.37
Согласно последним финансовым отчетам и цене акций Ensysce Biosciences, Inc., текущий EPS компании (TTM) составляет $-6.37. В конце 2023 EPS компании составлял $-4.69, больше, чем показателю 2022 года, равному $-139.44.
История EPS компании Ensysce Biosciences, Inc. с 2017 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-6.37 39.39%
2024 $-4.57 -2.56%
2023 $-4.69 -96.64%
2022 $-139.44 -60.80%
2021 $-355.68 -63,614.29%
2020 $0.56 133.33%
2019 $0.24 -209.09%
2018 $-0.22 4,130.77%
2017 $-0.01 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$3.62 -156.86%
DK
$15.47 -342.86%
US
$43.12 -776.92%
US
$9.62 -251.03%
BE
$2.98 -146.78%
AU